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ABSTRACT
The synthesis, characterization and biological assays of two new rhodium carboxylate sugar derivatives and
respective cyclosphosphamide adducts are described. The compounds, characterized by q3C and IH NMR,
infrared and UV-visible spectra, presented high water solubility and hydration grades were confirmed given the
concordance between thermal and CHN analyses. The adducts were active in vitro against K-562 cells.
INTRODUCTION
Ever since Rosenberg et al. introduced cisplatin in turnout disease therapeutics, researchers became
increasingly interested in this field, giving rise to a number of published findings on platinum group metal
complexes. In 1972, Bear and co-workers reported that rhodium (II) carboxylates present anti-tumoural
activity 2. Albeit the promising start, interest in this class of compounds as anti-tumoural agents has
somewhat decreased mostly in view of significant toxicity levels. Currently, a number of papers have been
issued in an attempt to identify less toxic derivatives 3-8.
One of the best means of obtaining chemotherapeutical metal complexes is to synthesize adducts using ligand
molecules that are, by their very nature, biologically active. To this effect, cyclophosphamide (CP) (Fig.l)
has been used to obtain adducts with rhodium(II) carboxylates. The compounds were submitted to biological
assays and results indicated that the complexes were not active 9. This might be partially due to the fact that
these present somewhat low water solubility levels. With views to obtaining compounds that present the
appropriate partition coefficient for biological assays, two new rhodium(II) derivatives, Rhz(GU)4 and
Rh2(KG)4, rhodium glucuronate and rhodium keto-gluconate (Fig.l) respectively, plus their adducts with CP,
have been synthesized and characterized.
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Fig. Structure of the new rhodium(II) carboxylates and cyclophosphamide adducts
MATERIALS AND METHODS
Chemicals
Rhodium chloride hydrate, hemicalcium D-gluconate and hemicalcium 2-keto-D-gluconate dihydrate were
purchased from Aldrich, sodium D-glucuronate and Sephadex C-25 from Sigma, whilst Sephadex G-25 was
acquired from Pharmacia.
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Instruments
IH-NMR, 13C-NMR and 31p-NMR analyses were carried out in an Bruker Advanced 300 MHz spectrometer,
utilizing D20 as solvent. IR spectra were recorded on a 1750 FTIR-Perkin-Elmer analyzer, model 783,
employing KBr pellets. Elemental analyses were performed on 240 B or 2400 Perkin-Elmer analyzers. UV-
visible spectra were recorded on a Hitachi U-3000 spectrometer whilst for thermal analyses purposes, a
Shimadzu TGA-50 was utilized.
Synthesis
Tetrakis-dirhodium (II) glucuronate and tetrakis-dirhodium (II) keto-gluconate, two functional isomers whose
molecular formula is (Rh-(CsH9OsCOO)4( were prepared mixing 2.1 N solutions of the respective sugar salts
in water, with an mol.ll ethanolic solution of RhCI3.xH20, under reflux at 70C during 4-6 hours. The
resultant green solution was submitted to column chromatography with G-25 and C-25 Sephadex, rendering a
blue, limpid solution. The products presented some sugar properties, such as solubility and thermostability.
The derivatives were subsequently freeze-dried and resultant respective yields were 25 and 33%. Adducts were
prepared mixing mol.L- solutions of free rhodium carboxylates with a 3 mol.L- water methanol (1" 1)
solution of cyclophosphamide. The green solution obtained was likewise submitted to freeze drying, the
powder washed with cold dichloromethane and dried, under vacuum. The yields of both adducts were
approximately 80%.
Biological tests
Cytotoxicity
K562 human leukaemia cells were cultured in RPMI media supplemented by 10% fetal serum. To test drug
effectiveness, 105 cells were sown onto a 24 well plate containing mL of the same medium. The samples
were added to the wells so as to obtain 132 gg/L and 266 gg/L final concentrations. A sodium bicarbonate
solution was added to the control wells. Twenty-four hours after adding the compound, well conterrts were
collected, centrifuged, stained with Trypan Blue and cells were counted.
Resultant data were compared by means of the statistic chi square testl. When P _< 0.05, differences were
deemed to be statistically significant.
Preliminar toxicity assay
Toxicity was investigated in nine different groups of eight healthy male Balb-C mice, with a single ip dose of
up to 200mg/kg. Death and/or toxic effects were sought for, during 60 days.
RESULTS AND DISCUSSION
Table presents the results encountered in carbon, nitrogen and hydrogen analyses. Percentages were
compatible with the compounds’ high water affinity.
The first inflection of TGA curves (Fig.2) is relative to water lost to Rh2(KG)4xH20 and the hydration grade
(x=6-8 H20) depends on freeze drying conditions.
TABLE CHN analyses
Experimental (%) Calculated (%)
COMPOUND C % H% N % C% H% N %
Rhz(GU)4 6H20 26.62 4.62 26.53 4.45
Rhz(KG)4 8H20 25.51 4.63 25.68 4.67
Rhz(GU)4(CP)2 27.55 4.89 3.35 27.75 5.03 3.41
Rhz(KG)4(CP)2 28.35 4.79 3.15 28.37 4.89 3.48
Sugar salt, rhodium comgound and respective CP adduct’s major infrared assignments are
depicted in Table 2. Co, ordination modes are forecasted as of the stretched, asymmetric
(--1600 cm-) and symmetric (-1400 cm-l) values, of the coordinated carboxylate groups.
Average A(asym-sym) values under 200 cm-I allow for the discarding of the hypothesis of
occurrence of complex’s monodentate coordination l. Within the 3500-3000 cm-range, the
free D-glucuronic acid presents three broad bands centered at 3400, 3280 and 3160 cm-I due
to OH stretching. The first two are attributed to intermolecular interactions and the latter
might be related to an intramolecular hydrogen bond 2. Usually these bands are shifted to a
higher frequency when the sugar ligands coordinate to metals. It is worth noting that such
shafts may be influenced by the metal charge and consequently by the covalent character of
the metal-ligand bond. For instance, the Rhz(GU)4 highest energy band at 3400 cm-I in
12 sugar free acid, shifts to 3600 cm- in its sodium salt and to 3470 cm in calcium salt
remaining at approximately 3400 crn-t for the rhodium (II) dimer. This suggests that the
intermolecular hydrogen bonds of the free acids are analogous to those observed in the
rhodium derivatives.
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TABLE 2-IR assignments
Na(GU) Ca(GU); Rh2(OU)4 Rh2(KG)4 Rh2(GU)4(CP)2 Rh2(KG)4(CP)2
3602 3470 3412 3394 3424 3395
1605 1613 1606 1614
1433 1424 1433 1425
172 189 173 189
Assignments
VO-H
voco asym
voco syrn
(Vasm’Vsm)
TABLE 3 Rhodium carboxylates sugar derivativeH and 13C NMR shifts.
Rh2(GU)4
IH-RMN (D20, (5) 4.95 (d, HI), 4’38 (d, HI’), 3:88 (d,-H5), 3’43, 3 39 (H3, H5’), 3.31-2’96 (H2,
H4, H3’, H4’, H2’)
13C’RMN (D20, ppm) 189.5 (6), 188.5 (C6’), 95’94 (C1), 91.96 (CI’), 74.72 iC3’), 74.61 (C’5’),
73.76 (C2’), 73.65 (C3), 71.85 (C2), 71.33 (C5), 70.71 (C4), 70.58 (C4’)
HOCHCHCHCHCC
OH OH
Rh2(KG)4
’H-RMN (D20; 8) 3.75 (H3), 3.70 (d, H6): 3’5’723.0 (m, Hi, 3.52 (H4), 3.45-3.40 (d, H6).
13C’RMN iD20, ppm) 56 (C1), 97.30 (C2) 9519 (c3), 81 (C4), 78.06 (c4’),’ 73.30 (C5), 69.9
(c5’), 68.80 (C6), 63.95 (c6’)
Additional splitting is observed in the H-NMR spectra of the rhodium compounds as compared to other
derivatives such as the sodium and calcium salts of KG and GU. The extensive number of conformations in
sugar complexes supports this finding. The IH and 13C chemical shifts (Table 3) of these sugar compounds
when compared with their salt derivatives 14, present different characteristics, specially those related to the
decrease in the ionic character of the M-O bond.
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TABLE 4 IH, 13C and 31p NMR shifts of GUCP
Rc_ O6_/ O Rh L (ClCH 2CH2)2N--
H 9
/ a
C O
o
R= H OH
L 3 OH
1H NMR (D20, 5)
13C NMR (D20 ppm)
31p NMR (D20, ppm)
’4.95(d,H1), 4.38-3.07(HS,Hl’,H7,H10,H11,H3,H3’,H2,H4,H4’,H5",H2,
H2’), 1.89-1.84(H8)
189.5(C6), 188.5(C6’), 95.95(C1), 95.61(C1’), 74.73(C3’), 74.60(C5’),
73.44(C2’), 73.24(C3), 71.85(C2), 71.29(C5), 70.73(C4), 70.61(C4’),
62.54(C7), 62.46(C7’), 49.38(C10), 49.05(C10’), 42.39(Cll), 42.81(C11’),
38.90(C9), 26.22(C8), 26.13(C8’)
13.57, -1.34, -12.70
Such diverse characteristics are better demonstrated by means of 3C spectral analyses whereby carboxyl
carbon signals shift to the 13 ppm downfield in the rhodium (II) complexes. This might be due to the fact
that as the carboxylic oxygen coordinates to rhodium(II), electronic displacements occur, deshielding the
carbon atom. Therefore this is in agreement with the infrared results, suggesting a higher covalent character to
the Rh-O bond.
TABLE 5 H, 3C and 3p NMR shifts of KGCP
H NMR (D20, 5)
RIC,/ O /h*O. L = (ClCH 2CH 2)2 N---"
H 9 .Xo// 0 x’. C.----.-R
R/Ox O’_ Rh ...._.oX_ 5 ?
O
o /x *=
L OH OH
4.95(d,Hi) 4.38 3.07(H5,HI’,H7,H10H11,H3,H3’,H2,H4,H4’,H5’,H2,
H2’), 1.89-1.84(H8)
13C NMR (D20, ppm)
3p NMR (D2O, ppm)
189.5(C1), 188.5(C1’), 95.95(C2), 95.61(C2’), 74.73(C3’), 74.60(C5’),
73.44(C2’), 73.24(C3), 71.85(C2), 71.29(C5), 70.73(C4), 70.61(C4’), 62.54,
62.46(C7,C7’), 49.38, 49.05(C10, C10’), 42.39, 42.81(Cll,Cl1’),
38.90(C9), 26.22, 26.13(C8,C8’)
1355, 9.35, 0.41,-1.35,-1.63,-12.70
H. OH o.. HO H O
H, ,,,, H
,* H
HO /k A COOH HO HO HH OH
fla zig-zag
Fig. 3- Possible conformations of KG
CO OH
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All signals in the cyclic derivative (GU) related to
both anomeric forms o and 13 (the latter represented
by ’) were identified and carefully assigned as per
literature data 9,14-18. Two possible conformations
15-17 (Fig.3) explained the additional shifts
(represented by ’) encountered in keto-gluconate
compounds. This effect was most intense in carbon
6.
In addition, with reference to the keto-gluconate
compounds, a carbonyl group that presented an
atypical signal at approximately C.ao 97 ppm was
identified. In conclusion, the displacement was
probably due to a keto-enolic equilibrium.
Nevertheless, it is worth emphasizing that other
than 31p NMR, few important shifts were observed
after axial CP coordination in the H and 13C NMR
spectra.
Fig. 4- 31p spectra of free CP (C) and their
rhodium adducts:[Rh2(KG)4(CP)2] (A) and
[Rhz(GU)4(CP)2 (B)
H, 3C and 31p NMR shift data are pictured in
Table 4, while Table 5 presents those for
Rhz(RCOO)4(CP)2, R=GU and KG, respectively.
Figure 4 depicts the 31p NMR spectra for both
adducts and the free CP.
Additional peaks in the spectra of adducts were
observed in 31p NMR. The first signal at +13.55
ppm is assigned to free CP ligand and agrees with
the dissociation of the adducts. A downfield shift of
the 31p peaks for the (Rhz(KG)4 (CP)2( and
(Rhz(GU)4 (CP)2( was expected, but not confirmed
9. The signal of these complexes appeared at-1.35
ppm and 1.34 ppm. This might be due to a prompt
dissociation of the adduct, forming Rhz(RCOO)4
and CP in water solution in view of the higher
donor character of D20 in relation to that of CDC13.
The third peak, at-12.7 ppm, is probably related to
(Rh2(RCOO)4 (CP)2(H20)(upon partial
dissociation.
Electronic spectra (Table 6) exhibit the four
characteristic peaks, "the finger print" of rhodium
carboxylates.
Existing literature 9 reports that cyclophosphamide
is not a ligand that presents high affinity with
rhodium(II) carboxylates. A link via the oxygen
P=O was involved when adducts were isolated. In
addition, should this have been due to a nitrogen
link, the compound would most probably have been
pink in colour, although there are exceptions. In
support of this hypothesis, the 590 nm band in
UV/vis spectra (Table 6) suggests, as observed in
other ligands, a coordination through oxygen.
Although data indicate that oxygen coordination is
most probable, the alternative nitrogen coordination
via hydrogen bonds could not be discarded.
BIOLOGICAL TESTS
Table 7 presents the results of cytotoxic activity.
Data was submitted to the statistical chi squared %2
test.
Although all compounds presented higher in vitro
activity in relation to the control, no deaths or toxic
effects were observed along the 60 days of its vivo
tests using doses of up to 200mg/kg. The group
treated with adducts showed a significant increase of
cytotoxicity in vitro, mostly in the highest doses.
The most promising in the series, against the cell
line tumour used, was the KG derivative. On the
other hand, it is worth noting that Rhz(KG)4(CP)2
presented higher activity than the CP and Rhz(KG)4
from which it is derived. Possibly, once these
adducts are administered, a gradual dissociation
occurs before acting upon the cancer cells. Should
this be the case, both rhodium carboxylates and CP
meet each other’s requirements as carriers,
promoting a synergistic effect in vivo. The
relevance of this effect requires further investigation
and will be subject to forthcoming studies.
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TABLE 6- UV-visible assignments
peak Rh2(RCOO)4 Rh2(RCOO)4(CP)2
590 nm 590 nm
2 460 nm 438 nm
3 (shoulder) 240 nm 225 nm
4 200 nm 200 nm
’R= K’d’ ou Gu
Compound
TABLE 7 C’totoxic activity,
Dead Cells Living Cells Total Dead Cells
(x 104 cells/mL) (x 104 cells/mL) (x 104 cells/mL) (%)
132 lag/L 266 tg/L 132 g/L 266tg/L 132 I.tg/L 266 g/L 132 g/L 266 g/L
Rh2(GU)4 0 5 3 5 4 0 25
Rh2(KG)4 0 6 5 6 0 17
Rh2(GU)4(CP)2 3 4 2 5 5 20 60
Rh2(KG)4(CP)2 4 6 5 9 7 44 86
Control 39 40 5
CP 0 0 6 3 6 3 0 0
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